We are live on ! Find out more
IRWD icon

Ironwood Pharmaceuticals

221 hedge funds and large institutions have $674M invested in Ironwood Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 69 increasing their positions, 77 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

92,654% more call options, than puts

Call options by funds: $46.4M | Put options by funds: $50K

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

2% less funds holding

Funds holding: 226221 (-5)

5.47% less ownership

Funds ownership: 107.8%102.34% (-5.5%)

10% less repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 77

11% less first-time investments, than exits

New positions opened: 39 | Existing positions closed: 44

40% less capital invested

Capital invested by funds: $1.12B → $674M (-$443M)

Holders
221
Holders Change
-5
Holders Change %
-2.21%
% of All Funds
3.17%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
39
Increased
69
Reduced
77
Closed
44
Calls
$46.4M
Puts
$50K
Net Calls
+$46.3M
Net Calls Change
-$27.1M
Name Holding Trade Value Shares
Change
Change in
Stake
MIM
101
MetLife Investment Management
New Jersey
$332K
SOADOR
102
State of Alaska Department of Revenue
Alaska
$330K -$10.3K -1,911 -2%
SO
103
STRS Ohio
Ohio
$316K -$23.7K -4,400 -5%
Tudor Investment Corp
104
Tudor Investment Corp
Connecticut
$310K +$405K +75,287 New
LSERS
105
Louisiana State Employees Retirement System
Louisiana
$280K -$12.9K -2,400 -3%
OWIM
106
Old West Investment Management
California
$280K +$8.11K +1,509 +2%
ETC
107
Exchange Traded Concepts
Oklahoma
$279K +$364K +67,691 New
Daiwa Securities Group
108
Daiwa Securities Group
Japan
$278K +$63.4K +11,800 +21%
JF
109
Jump Financial
Illinois
$273K +$356K +66,189 New
Janus Henderson Group
110
Janus Henderson Group
United Kingdom
$272K
Wells Fargo
111
Wells Fargo
California
$268K +$7.27K +1,353 +2%
State of Tennessee, Department of Treasury
112
State of Tennessee, Department of Treasury
Tennessee
$267K -$14K -2,613 -4%
US Bancorp
113
US Bancorp
Minnesota
$257K +$285 +53 +0.1%
Handelsbanken Fonder
114
Handelsbanken Fonder
Sweden
$245K +$62.4K +11,600 +24%
HT
115
Headlands Technologies
Illinois
$227K +$142K +26,452 +92%
VEA
116
Virtus ETF Advisers
New York
$227K
ECM
117
EMC Capital Management
Texas
$225K -$112K -20,880 -87%
Manulife (Manufacturers Life Insurance)
118
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$225K -$121K -22,552 -29%
SPA
119
Sherbrooke Park Advisers
New York
$209K +$273K +50,701 New
MSRPS
120
Maryland State Retirement & Pension System
Maryland
$201K
PAM
121
Panagora Asset Management
Massachusetts
$199K +$260K +48,333 New
GCM
122
Gallacher Capital Management
Colorado
$199K +$98.4K +18,301 +61%
VOYA Investment Management
123
VOYA Investment Management
Georgia
$197K -$176K -32,749 -41%
Allspring Global Investments
124
Allspring Global Investments
North Carolina
$186K -$28.2K -5,243 -10%
Mariner
125
Mariner
Kansas
$186K -$189K -35,216 -44%

IRWD Hedge Fund Activity: Q3 2024 in Review

221 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Ironwood Pharmaceuticals (IRWD) for Q3 2024, worth a combined $674M — down 40% from $1.12B a quarter earlier.

Sellers outnumbered buyers: 44 funds closed out of IRWD and 39 opened new positions — a net loss of 5 holders — while 77 trimmed existing stakes and 69 added.

The largest buyer was Pacer Advisors, adding an estimated $12.8M. The largest seller was Brown Capital Management, exiting entirely with an estimated $16.8M sold.

  • 221 institutional investors held Ironwood Pharmaceuticals (IRWD) as of Q3 2024, down from 226 in Q2 2024.
  • Funds reported $674M of Ironwood Pharmaceuticals stock for Q3 2024, down 40% quarter-over-quarter.
  • 39 funds opened new Ironwood Pharmaceuticals positions in Q3 2024 and 44 closed out, a net change of -5 holders.
  • The largest Ironwood Pharmaceuticals buyer in Q3 2024 was Pacer Advisors, an estimated $12.8M added.
  • The largest Ironwood Pharmaceuticals seller in Q3 2024 was Brown Capital Management, an estimated $16.8M sold.

Based on aggregated 13F filings for Q3 2024.